Has Gerald Gordon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,573 in general payments to Gerald Gordon, MD across 577 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gerald Gordon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gerald Gordon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gerald Gordon, MD

Internal Medicine · Aiken, SCNPI 1396738753

Payments from drug & device makers

$12,573in general payments, 2019–2025

Across 577 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
AbbVie$945
Insmed, Inc.$938
Lilly USA, LLC$880
Novo Nordisk$806
Novartis$757
plus $7K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	57	$1,595
AbbVie(2 entities)	42	$945
Insmed, Inc.	52	$938
Lilly USA, LLC	49	$880
Novo Nordisk	45	$806
Novartis	31	$757
Gilead	6	$435
GSK	20	$370
Organogenesis Inc.	3	$355
Amgen	12	$349
Merck	24	$329
Melinta Therapeutics, LLC	11	$327
Corcept Therapeutics	10	$292
Pfizer	18	$272
Boehringer Ingelheim	13	$228
Sanofi-aventis U.S. LLC	10	$215
Astellas Pharma US Inc	9	$202
Bayer	7	$201
Viiv Healthcare Company	13	$201
Inari Medical, Inc.	2	$189
Insulet Corporation	8	$165
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	10	$153
Takeda Pharmaceuticals U.S.A., Inc.	8	$147
Kerecis Limited	1	$137
Paratek Pharmaceuticals, Inc.	8	$133
Amarin Pharma, Inc.	7	$125
Zealand Pharma US, Inc.	7	$121
Mannkind Corporation	6	$114
VBI Vaccine (delaware) Inc.	5	$106
Abbott	6	$103
Xeris Pharmaceuticals, Inc.	5	$102
Dexcom, Inc.	8	$100
Johnson & Johnson(2 entities)	7	$89
Cequr Corporation	2	$88
Exact Sciences	4	$73
Arbor Pharmaceuticals, Inc.	5	$70
Daiichi Sankyo Inc.	3	$67
Shionogi Inc	3	$65
BETA Bionics, Inc.	3	$64
Theratechnologies Inc.	4	$59
Lundbeck LLC	2	$54
Radius Health, Inc.	2	$47
Ferring Pharmaceuticals Inc.	2	$41
Boston Scientific	2	$41
Medtronic(2 entities)	2	$29
Hydrofera LLC	1	$28
Mylan Specialty L.p.	2	$28
Otsuka America Pharmaceutical, Inc.	1	$28
Grifols USA, LLC	1	$27
Eisai Inc.	2	$26
Kowa Pharmaceuticals America, Inc.	2	$26
Stryker	1	$21
Vyera Pharmaceuticals, LLC	1	$21
Cvrx, Inc.	1	$19
Aimmune Therapeutics, Inc.	1	$18
Si-bone, Inc.	1	$17
La Jolla Pharmaceutical Company	1	$17
Tetraphase Pharmaceuticals, Inc.	1	$17
Esperion Therapeutics, Inc.	1	$16
Biohaven Pharmaceuticals, Inc.	1	$15

How this compares

$12,573 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$347,602

Medicare patients

900

Services billed

9,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Aiken

Rica SantiagoMt Pleasant$10.7M
Richard MillsMt Pleasant$5.5M
Yvonne DavisMount Pleasant$2.4M
David BolsterSummerville$2.3M
Colby GrossmanSummerville$1.4M
Amit ShahIndian Land$1.4M
Philip NicolMurrells Inlet$782K
Carl SofleyAnderson$673K
Carl MitchellColumbia$564K
Jerry BackNorth Charleston$322K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →